UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF
SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF
THE SECURITIES EXCHANGE ACT OF 1934

Intelligent Medicine Acquisition Corp. 

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation or
organization) 86-2283527
(I.R.S. Employer Identification
Number)

9001 Burdette Rd.
Bethesda, MD
(Address of principal executive offices) 20817
(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered	Name of each exchange on which each class is to be registered
Units, each consisting of one Class A Common Stock and one- half of one redeemable warrant	The Nasdaq Stock Market LLC
Class A Common Stock, $0.0001 par value per share	The Nasdaq Stock Market LLC
Redeemable warrants, each whole warrant exercisable for one share	The Nasdaq Stock Market LLC
of Class A Common Stock at an exercise price of $11.50

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-260205 (if applicable)

Securities to be registered pursuant to Section 12(g) of the Act: None

(Title of class) 

N/A

Item 1. Description of Registrant’s Securities to Be Registered.

The securities to be registered hereby are the units, Class A common stock, par value $0.0001 per share, and redeemable warrants, with each whole warrant exercisable for one share of Class A common stock of Intelligent Medicine Acquisition Corp (the “Company”). The description of the units, Class A common stock and redeemable warrants contained in the section entitled “Description of Securities” in the prospectus included in the Company’s Registration Statement on Form S-1 (File No. 333-260205), originally filed with the Securities and Exchange Commission on October 13, 2021, as thereafter amended and supplemented from time to time (the “Registration Statement”), to which this Form 8-A relates, is incorporated herein by reference. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is also incorporated by reference herein.

Item 2. Exhibits.

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Company are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

Date: November 4, 2021     

INTELLIGENT MEDICINE ACQUISITION CORP
By:	/s/Gregory C. Simon
	Name: Gregory C. Simon
	Title:   Chief Executive Officer and Chief Financial Officer